A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Conditions
Leukemia, Juvenile Myelomonocytic · JMML · JCML · Neurofibromatosis 1 · CBL Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Phoenix Children's Hospital, Phoenix, Arizona, United States
Contact: Study coordinator (Dana Salzberg, MD)Children's Hospital Los Angeles, Los Angeles, California, United States
Contact: Study coordinator (Jaime Stokke, MD)University of California San Francisco, San Francisco, California, United States
Contact: Study coordinator (Elliot Stieglitz, MD)Children's Hospital of Colorado, Denver, Colorado, United States
Contact: Study coordinator (Kelly Faulk, MD)Children's National Medical Center, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Reuven Schore, MD)University of Miami, Miami, Florida, United States
Contact: Study coordinator (Julio Barredo, MD)Children's Hospital of Atlanta, Atlanta, Georgia, United States
Contact: Study coordinator (Melinda Pauly, MD)Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Jenna Rossoff, MD)Indiana University/Riley Hospital for Children, Indianapolis, Indiana, United States
Contact: Study coordinator (Sandeep Batra, MD)Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Contact: Study coordinator (Stacy Cooper, MD)C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States
Contact: Study coordinator (Jennifer Agrusa, MD)Children's Mercy Hospital, Kansas City, Missouri, United States
Contact: Study coordinator (Keith August, MD)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Kavitha Ramaswamy, MD)Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Study coordinator (Lauren Pommert, MD)Oregon Health & Science University, Portland, Oregon, United States
Contact: Study coordinator (Bill Chang, MD)Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Sarah Tasian, MD)St. Jude Children's Research Hospital Memphis, Memphis, Tennessee, United States
Contact: Study coordinator (Seth Karol, MD)Primary Children's Hospital, Salt Lake City, Utah, United States
Contact: Study coordinator (Mallorie Heneghan, MD)Seattle Children's Hospital, Seattle, Washington, United States
Contact: Study coordinator (Mignon Loh, MD)